CMMB - Chemomab Therapeutics Ltd (CMMB) CEO Dale Pfost on Q4 2021 Results - Earnings Call Transcript
Chemomab Therapeutics Ltd (CMMB) Q4 2021 Earnings Conference Call March 9, 2022, 10:00 AM ET Company Participants Dale Pfost – Chief Executive Officer Donald Marvin – Chief Operating Officer and Executive Vice President David Weiner – Chemomab Interim Chief Medical Officer Barbara Lindheim – Consulting Vice President Investor & Public Relations Conference Call Participants Kristen Kluska – Cantor Fitzgerald Nathan Weinstein – Aegis Capital Presentation Operator Greetings. Welcome to Chemomab Fourth Quarter and Full Year 2021 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note this conference is being recorded. I will now turn the conference over to Barbara Lindheim, Vice President and Investor Relations. Thank you. You may begin. Barbara Lindheim Welcome to the Chemomab Therapeutics 2021 Fourth Quarter and Full Year Results Conference Call. Thank you for attending. I am Barbara Lindheim, consulting
For further details see:
Chemomab Therapeutics Ltd (CMMB) CEO Dale Pfost on Q4 2021 Results - Earnings Call Transcript